Atlas Trials

Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)

Clinical trial NCT02676154 · COMPLETED

Trial details

NCT number
NCT02676154
Sponsor
University of British Columbia
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Autonomic Dysreflexia
Start date
2016-02-25
Primary completion
2019-01-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.